A detailed history of Global Retirement Partners, LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Global Retirement Partners, LLC holds 5,514 shares of VKTX stock, worth $226,956. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,514
Previous 5,637 2.18%
Holding current value
$226,956
Previous $298,000 17.11%
% of portfolio
0.01%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$49.84 - $70.47 $6,130 - $8,667
-123 Reduced 2.18%
5,514 $349,000
Q2 2024

Jul 23, 2024

BUY
$47.39 - $80.2 $219,036 - $370,684
4,622 Added 455.37%
5,637 $298,000
Q1 2024

Apr 23, 2024

BUY
$17.4 - $94.5 $9,831 - $53,392
565 Added 125.56%
1,015 $83,000
Q4 2023

Jan 18, 2024

SELL
$9.24 - $19.64 $462 - $982
-50 Reduced 10.0%
450 $8,000
Q3 2023

Oct 13, 2023

BUY
$10.92 - $16.0 $5,460 - $8,000
500 New
500 $5,000
Q1 2022

Jul 14, 2022

BUY
$3.0 - $4.88 $42 - $68
14 New
14 $0

Others Institutions Holding VKTX

About Viking Therapeutics, Inc.


  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $3.16B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Global Retirement Partners, LLC Portfolio

Follow Global Retirement Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Retirement Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Global Retirement Partners, LLC with notifications on news.